What is ARPIM?
The Romanian Association of International Medicines Manufacturers (ARPIM), the professional organization of the major pharmaceutical companies' representatives in Romania. ARPIM is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
In 2006, its tenth year of existence, the association includes 23 members, pharmaceutical companies with a long history and a vast experience in researching and developing medicines.
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the medicine producing industry operating in Europe. Its members are national pharmaceutical industry associations from over 20 countries, uniting over 40 leading pharmaceutical companies. Most EFPIA member companies are also present in Romania.
EFPIA's and, implicitly, ARPIM's mission is to promote the advances made by the pharmaceutical industry, subsequent to its technological and economical growth in Europe, and to assist the marketing of medicines resulted from scientific research, in order to improve the population's general health. |
Ongoing activities
Sanatatea - prioritate pentru Romania
Asociatia Romana a Producatorilor Internationali de Medicamente (ARPIM) asista cu ingrijorare la deteriorarea accelerata a performantelor sistemului sanitar, fenomen care a culminat in anul 2009 cu retrogradarea Romaniei pe penultimul loc dintr-un grup de 33 de tari europene (Conform European Healthcare Index 2009). Ca urmare, ARPIM solicita Ministerului Sanatatii elaborarea unei politici publice in domeniul sanatatii dezvoltata in parteneriat cu producatorii de medicamente, asociatii profesionale si alte parti interesate.
Document de pozitie ARPIM (PDF, 199kb)
Fundamentare pozitie ARPIM (PDF, 288kb)
"Research Saves Lives" informing campaign
It is a population informing campaign about the role of the pharmaceutical companies in finding efficient therapies and eradicating diseases.
The creative approach in the "Research Saves Lives" campaign brings forward the purpose of existence and the achievements of the major pharmaceutical companies.
The primary message of the campaign is that the time and financial resources invested in research by the major pharmaceutical companies generated therapies that successfully fight diseases formerly thought to be incurable.
The secondary message shows that, as long as there are diseases, the major pharmaceutical companies are making it their duty to continue the research, in the quest of finding new, efficient, therapies.
Finally, the slogan "Research Saves Lives", concentrates in a persuasive phrase the message of the entire campaign, of increased awareness of the benefits that pharmaceutical industry research brings in everyone's lives. |
The ARPIM Code of Ethics in Medicine Promotion
The ARPIM Code of Ethics in Medicine Promotion is a document developed by the ARPIM Ethical Issues Workgroup, which regulates the process of promoting prescription based drugs, formulates the minimal conduct standards that ARPIM members should comply with, to create an ethical competitive environment, and suggests financial or/and administrative sanctions to be applied in case of Code violation.
In January 2007 Romania becomes an EU member. In order to provide ethical standards as high as those applied in the pharmaceutical industry promotion in EU, ARPIM feels that it is imperative to implement a conduct code similar to the one applied in EU countries. Thus, the ARPIM Code of Ethics in Medicine Promotion will be the reference by which the medicine promotion legal activities will be judged.
Arpim Code of Ethics, full document (PDF, 171kb)
|
The ARPIM Code regarding the interaction with Patient Organisations
Numerous actions for the promotion and supporting of the patients' rights have been going on in Romania lately, with mainly the purpose of increasing the representation and involvement of the patient organisations on a legislative and administrative level. One of the actions taken was setting up the Chronic Diseases Patient Organisation Coalition in Romania (COPAC) on April 20th 2008. The event was admitted to be an important landmark for the discussions with the authorities and with the Public Health Ministry.
Trying to meet the specific needs of the civil society, ARPIM adopted on June 26th 2008 the Practice Code on the partnerships with patient organisations, according to principles established by EFPIA (European Federation of Pharmaceutical Industries and Associations) on an European level.
The Public Health Ministry believes that increased access to information can improve disease prevention, can lead to early diagnosis and therefore to better treatment and better patient compliance. During research activities, pharmaceutical companies have accumulated a large number of information on health, disease and treatment. This fact, together with the long relationship with the health care providers and the increased focus on the patients means that the pharmaceutical industry can bring its contribution to the protection of public health.
The current initiative is integrated in an effort on a European level to increase the transparency of market practices and to provide ethical relationships with patient organisations, admitting at the same time their independence.
Full document (PDF, 88kb)
|
